Cleerly Funding & Investors
New York, NY
Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. We are developing a new standard for coronary artery disease by integrating the highest quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, we aim to provide a comprehensive solution for cardiovascular disease evaluation that offers the greatest value to the healthcare system and improves heart health for patients at risk of heart attacks.
cleerlyhealth.comTotal Amount Raised: $386,484,992
Cleerly Funding Rounds
Series C
$106,000,000
Series C Investors
Insight Venture PartnersBattery VenturesSeries C
$223,000,000
Series C Investors
FidelityT. Rowe PricePiper Heartland Healthcare CapitalBreyer CapitalSands Capital ManagementNew Leaf VenturesMirae Asset CapitalNovartisPeter ThielDigiTx PartnersVensana CapitalCigna VenturesLRVHealthPresight CapitalTHE CATALYTIC IMPACT FOUNDATION (CIF)Series B
$43,000,000
Series B Investors
Vensana CapitalNew Leaf Venture PartnersAmerican College of CardiologyDigiTx PartnersCigna VenturesLRVHealthJay ZaveriSeries A
$14,484,975
Funding info provided by Diffbot.